(Press-News.org) NEW ORLEANS, LOUISIANA— Ochsner Health, Louisiana’s largest nonprofit, academic, multi-specialty, healthcare delivery system, has received the 2023 Gallup Exceptional Workplace Award (GEWA). This award recognizes the most engaged workplace cultures in the world.
After another year of unpredictability in the workplace, Gallup found that Ochsner Health continued to put their employees’ engagement at the center of their business strategy, embedding engagement into their very culture.
“Our employees are the reason for the culture of positive engagement at Ochsner Health. From physicians and providers to clinical and non-clinical staff, Ochsner employees take pride in their work and administer care with compassion, resulting in positive outcomes and high-quality healthcare for our patients. We are honored for our organization to receive this recognition from Gallup as we work daily to foster a workplace built on integrity, compassion, inclusivity, excellence and teamwork,” said Tracey Schiro, executive vice president and chief human resources officer, Ochsner Health.
“Gallup’s 2023 GEWA winners proved that even during some of the most challenging times, strong cultures are resilient and find new ways to get work done and meet customer needs. These organizations continued to make employee engagement a central cultural priority as part of their business strategy, and they maintained record levels of employee engagement while achieving or exceeding their business goals,” said Jim Harter, Gallup’s chief scientist of workplace management and wellbeing.
GEWA winners’ ratio of engaged employees to actively disengaged employees is 16 times higher than the international average. Worldwide, only 21% of employees are engaged — that is, committed to their work and connected to their workplace — and just 32% of employees in the U.S. workforce are engaged. Seventy-two percent of employees at winning GEWA organizations are engaged.
In 2022, Ochsner’s engagement reached an all-time high and was in the 86th percentile across healthcare organizations in the country.
“At Ochsner Health, we value our employees and their daily commitment to excellence as they care for our patients and community. They are the essence of our organization, making our workplace culture one of which to be proud,” said Pete November, chief executive officer, Ochsner Health. “Ochsner has significantly invested resources and programs to elevate our employee engagement and experience. This award represents Ochsner Health’s investment in a healthy workplace culture and overall employee experience.”
Gallup’s meta-analysis on team engagement and performance is the most comprehensive workplace study ever conducted, with data on more than 2 million employees in 276 organizations across 54 industries and 96 countries. Highly engaged organizations significantly outperform their peers in important business outcomes, including customer ratings, profitability, productivity, turnover, safety incidents, shrinkage, absenteeism, quality, wellbeing and organizational citizenship.
For a complete list of GEWA winners and more about the selection process, visit the winners’ page.
###
About Ochsner Health
Ochsner Health is an integrated healthcare system with a mission to Serve, Heal, Lead, Educate and Innovate. Celebrating 80 years in 2022, it leads nationally in cancer care, cardiology, neurosciences, liver and kidney transplants and pediatrics, among other areas. Ochsner is consistently named both the top hospital and top children’s hospital in Louisiana by U.S. News & World Report. The not-for-profit organization is inspiring healthier lives and stronger communities. Its focus is on preventing diseases and providing patient-centered care that is accessible, affordable, convenient and effective. Ochsner Health pioneers new treatments, deploys emerging technologies and performs groundbreaking research, including 4,000 patients enrolled in 685 clinical studies in 2022. It has more than 38,000 employees and over 4,600 employed and affiliated physicians in over 90 medical specialties and subspecialties. It operates 48 hospitals and more than 370 health and urgent care centers across Louisiana, Mississippi, Alabama and the Gulf South; and its cutting-edge Connected Health digital medicine program is caring for patients beyond its walls. In 2022, Ochsner Health treated more than 1.4 million people from every state and 62 countries. As Louisiana’s top healthcare educator of physicians, Ochsner Health and its partners educate thousands of healthcare professionals annually. To learn more, visit https://www.ochsner.org/.
About Gallup
Gallup delivers analytics and advice to help leaders and organizations solve their most pressing problems. Combining more than 80 years of experience with its global reach, Gallup knows more about the attitudes and behaviors of employees, customers, students and citizens than any other organization in the world.
END
Ochsner Health named 2023 Gallup Exceptional Workplace Award Winner
2023-03-29
ELSE PRESS RELEASES FROM THIS DATE:
Heart attack study could change the game in regenerative medicine
2023-03-29
LA JOLLA, CALIF. Mar 29, 2023 - Sanford Burnham Prebys researchers have identified a group of proteins that could be the secret to cellular reprogramming, an emerging approach in regenerative medicine in which scientists transform cells to repair damaged or injured body tissues. The researchers were able to reprogram damaged heart cells to repair heart injuries in mice following a heart attack. The findings, which appear in the journal Nature Communications, could one day transform the way we treat a variety of diseases, including cardiovascular disease, Parkinson’s ...
Do your headaches happen at the same time of day?
2023-03-29
EMBARGOED FOR RELEASE UNTIL 4 P.M. ET, WEDNESDAY, MARCH 29, 2023
MINNEAPOLIS – Both cluster headache and migraine have strong links to the circadian system, the internal clock that regulates body processes, according to a meta-analysis published in the March 29, 2023, online issue of Neurology®, the medical journal of the American Academy of Neurology.
The meta-analysis included all available studies on cluster headache and migraine that included circadian features. This included information on the timing of headaches during ...
Imaging brain connections can predict improvements in obsessive-compulsive disorder patients after deep brain stimulation
2023-03-29
Deep brain stimulation (DBS) is a promising therapy for treatment-resistant obsessive-compulsive disorder (OCD). A first-of-its-kind collaborative study led by researchers at Texas Children’s Hospital, Baylor College of Medicine, and Brigham & Women’s Hospital has found that mapping neural connections in the brains of OCD patients offers key insights that explain the observed improvements in their clinical outcomes after DBS. The study was published in Biological Psychiatry.
Neuropsychiatric disorders such as obsessive-compulsive ...
Lab-made antibodies offer potential cure for yellow fever
2023-03-29
PORTLAND, Oregon -- New research from Oregon Health & Science University and collaborators indicates lab-made antibodies may be able to cure people infected with yellow fever, a virus for which there is no treatment.
The natural immune response to invading pathogens normally involves making protective proteins called antibodies. A study published today in Science Translational Medicine suggests that a single monoclonal antibody infusion can strengthen the body’s fight against yellow fever.
In the study, the yellow fever virus was undetectable in all animals that received monoclonal antibody infusions after being exposed to the virus.
“Two ...
Evermed, ACC launch ACC Anywhere, the 'Netflix of Cardiology'
2023-03-29
Evermed and the American College of Cardiology (ACC) have announced the launch of ACC Anywhere, a new content hub that provides cardiologists around the world with on-demand access to the latest clinical knowledge. The hub contains original content from five conferences including ACC’s 2022 and 2023 Annual Scientific Session, with additional conferences to be added in the future.
Evermed was selected to collaborate with ACC due to its advanced AI-powered recommender engine and its ability to effectively deliver medical education content 365 days per year. In addition, Evermed’s technology will help drive yearlong engagement to ensure that users are able ...
The clinical presentation of IDDMSSD syndrome is likely associated with the molecular location of the mutation in the PAK1 gene
2023-03-29
A recent study from Texas Children’s Hospital and Baylor College of Medicine has expanded the clinical spectrum of a new epileptic disorder called Intellectual Developmental Disorder with Macrocephaly, Seizures, and Speech Delay (IDDMSSD) with the identification of the first recurrently affected residue identified in the protein kinase domain of PAK1 protein. The study, published in the American Journal of Medical Genetics: Part A, found potential correlations between how and which organ ...
Downregulation of angulin-1/LSR induces malignancy in lung adenocarcinoma
2023-03-29
“In the present study, we found that downregulation of angulin-1/LSR induced malignancy via upregulation of EGF-dependent CLDN-2 and TGF-β-dependent cell metabolism in human lung adenocarcinoma.”
BUFFALO, NY- March 29, 2023 – A new research paper was published in Oncotarget's Volume 14 on March 24, 2023, entitled, “Downregulation of angulin-1/LSR induces malignancy via upregulation of EGF-dependent claudin-2 and TGF-β-dependent cell metabolism in human lung adenocarcinoma A549 cells.”
Abnormal expression of bicellular tight junction claudins, including ...
Bridging the Gap: addressing medical and social needs improves diabetes care and outcomes
2023-03-29
Nearly one in five American adults has diabetes. But that doesn’t mean the common condition is simple to treat or manage. Diabetes and its complications are the No. 1 cause of kidney failure, adult blindness, and lower-limb amputations. It’s also the seventh-leading cause of death in the U.S. As with so many chronic conditions, diabetes also disproportionately affects the most vulnerable in our communities, further exacerbating existing health disparities.
In a new supplemental issue of the ...
Research Brief: Study finds evidence of resistance to COVID-19 drugs
2023-03-29
(03/29/2023) — Resistance to Paxlovid is already evident among viral SARS-CoV-2 variants currently circulating globally, indicating that this stand-alone drug known as a protease inhibitor could soon become less effective in treating COVID-19 infections.
This conclusion was presented in a study published today online in the peer-reviewed journal Science Advances.
This study — conducted by the Midwest Antiviral Drug Discovery (AViDD) Center — shows that drug-resistant variants have appeared multiple times independently in different parts of the world, with regional clusters providing evidence for person-to-person transmission. In ...
Senescence and extracellular vesicles: novel partners in vascular amyloidosis
2023-03-29
“[...] there has been limited research to date on the effect of cellular ‘ageing’, termed senescence, on amyloidosis.”
BUFFALO, NY- March 29, 2023 – A new editorial paper was published in Aging (listed by MEDLINE/PubMed as "Aging (Albany NY)" and "Aging-US" by Web of Science) Volume 15, Issue 5, entitled, “Senescence and extracellular vesicles: novel partners in vascular amyloidosis.”
In their editorial, researchers Meredith Whitehead, Marco Antonazzi and Catherine M. Shanahan from King’s College London discussed amyloidosis—a ...